⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
Securities Fraud Class Action Filed Against Aardvark Therapeutics, Inc. (AARD) - Levi & Korsinsky Reminds Investors of October 13, 2026
accessnewswire.com
AARD
Lost Money on Aardvark Therapeutics, Inc. (AARD)? Join Class Action Before October 13, 2026 – Contact Levi & Korsinsky
accessnewswire.com
AARD
Lost Money on Aardvark Therapeutics, Inc. (AARD)? Contact Levi & Korsinsky Before October 13, 2026 to Join Class Action
accessnewswire.com
AARD
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AARD
globenewswire.com
AARD
Lost Money on Aardvark Therapeutics, Inc. (AARD)? Join Class Action Before October 13, 2026 - Contact Levi & Korsinsky
accessnewswire.com
AARD
Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD
globenewswire.com
AARD
Class Action Alert: Levi & Korsinsky Reminds Aardvark Therapeutics, Inc. (AARD) Investors of October 13, 2026 Deadline
accessnewswire.com
AARD
Class Action Lawsuit Filed: Aardvark Therapeutics, Inc. (AARD) - Join by October 13, 2026 - Contact Levi & Korsinsky
accessnewswire.com
AARD
AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AARD
Bronstein, Gewirtz & Grossman LLC Urges Aardvark Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
AARD